• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建模环糊精对低溶解度药物口服吸收的影响:二、实验验证。

Modeling the influence of cyclodextrins on oral absorption of low solubility drugs: II. Experimental validation.

机构信息

Northeastern University, Snell Engineering Center, Boston, Massachusetts 02115, USA.

出版信息

Biotechnol Bioeng. 2010 Feb 1;105(2):421-30. doi: 10.1002/bit.22524.

DOI:10.1002/bit.22524
PMID:19725043
Abstract

A model was developed for predicting the influence of cyclodextrins (CDs) delivered as a physical mixture with drug on oral absorption. CDs are cyclic oligosaccharides which form inclusion complexes with many drugs and are often used as solubilizing agents. The purpose of this work is to compare the simulation predictions with in vitro as well as in vivo experimental results to test the model's ability to capture the influence of CD on key processes in the gastrointestinal (GI) tract environment. Dissolution and absorption kinetics of low solubility drugs (Naproxen and Nifedipine) were tested in the presence and absence of CD in a simulated gastrointestinal environment. Model predictions were also compared with in vivo experimental results (Glibenclamide and Carbamazepine) from the literature to demonstrate the model's ability to predict oral bioavailability. Comparisons of simulation and experimental results indicate that a model incorporating the influence of CD (delivered as a physical mixture) on dissolution kinetics and binding of neutral drug can predict trends in the influence of CD on bioavailability. Overall, a minimal effect of CD dosed as a physical mixture was observed and predicted. Modeling may aid in enabling rational design of CD containing formulations.

摘要

建立了一个模型来预测作为药物物理混合物给药的环糊精 (CD) 对口服吸收的影响。CD 是环状低聚糖,可与许多药物形成包合络合物,常用于增溶。这项工作的目的是将模拟预测与体外和体内实验结果进行比较,以测试模型捕捉 CD 对胃肠道 (GI) 环境中关键过程影响的能力。在模拟胃肠道环境中,测试了低溶解度药物(萘普生和硝苯地平)在存在和不存在 CD 的情况下的溶解和吸收动力学。还将模型预测与文献中的体内实验结果(格列本脲和卡马西平)进行了比较,以证明模型预测口服生物利用度的能力。模拟和实验结果的比较表明,纳入 CD(作为物理混合物给药)对溶解动力学和中性药物结合影响的模型可以预测 CD 对生物利用度影响的趋势。总体而言,观察到并预测了 CD 作为物理混合物给药的最小影响。建模可能有助于实现含 CD 配方的合理设计。

相似文献

1
Modeling the influence of cyclodextrins on oral absorption of low solubility drugs: II. Experimental validation.建模环糊精对低溶解度药物口服吸收的影响:二、实验验证。
Biotechnol Bioeng. 2010 Feb 1;105(2):421-30. doi: 10.1002/bit.22524.
2
Modeling the influence of cyclodextrins on oral absorption of low-solubility drugs: I. Model development.环糊精对低溶解度药物口服吸收影响的建模:I. 模型建立。
Biotechnol Bioeng. 2010 Feb 1;105(2):409-20. doi: 10.1002/bit.22523.
3
Model predicting impact of complexation with cyclodextrins on oral absorption.预测与环糊精络合对口服吸收影响的模型。
Biotechnol Bioeng. 2013 Sep;110(9):2536-47. doi: 10.1002/bit.24932. Epub 2013 Jul 10.
4
The utility of cyclodextrins for enhancing oral bioavailability.环糊精在提高口服生物利用度方面的效用。
J Control Release. 2007 Nov 6;123(2):78-99. doi: 10.1016/j.jconrel.2007.07.018. Epub 2007 Aug 16.
5
Drug salts and solubilization: modeling the influence of cyclodextrins on oral absorption.药物盐和增溶作用:环糊精对口服吸收影响的建模。
Ann Biomed Eng. 2011 Jan;39(1):455-68. doi: 10.1007/s10439-010-0169-1. Epub 2010 Oct 20.
6
The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-off.硝苯地平与选定环糊精的相互作用及随后的溶解度-渗透性权衡。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1293-9. doi: 10.1016/j.ejpb.2013.05.018. Epub 2013 Jun 11.
7
Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound.胶束溶液和包合物联合应用增强氟比洛芬的口服生物利用度。
Arch Pharm Res. 2010 Jan;33(1):95-101. doi: 10.1007/s12272-010-2231-9. Epub 2010 Feb 27.
8
Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation.新型缓释系统——尼伐地平固体分散颗粒崩解控制型骨架片(DCMT)的研制(II):体内评价
J Control Release. 2006 May 1;112(1):51-6. doi: 10.1016/j.jconrel.2006.01.020. Epub 2006 Mar 20.
9
Influence of cyclodextrin complexation on piroxicam gel formulations.环糊精包合对吡罗昔康凝胶制剂的影响。
Acta Pharm. 2005 Sep;55(3):223-36.
10
Cyclodextrins.环糊精
Toxicol Pathol. 2008 Jan;36(1):30-42. doi: 10.1177/0192623307310945.

引用本文的文献

1
Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures.β-拉帕醌及其环糊精复合物和物理混合物的肠道通透性
Eur J Drug Metab Pharmacokinet. 2016 Dec;41(6):795-806. doi: 10.1007/s13318-015-0310-5.
2
Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations.环糊精制剂增加亲脂性药物溶解度和降低渗透性的权衡。
PLoS One. 2013 Jul 16;8(7):e68237. doi: 10.1371/journal.pone.0068237. Print 2013.
3
The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs.
溶解度-渗透性相互作用及其对难溶性药物制剂设计和开发的意义。
AAPS J. 2012 Jun;14(2):244-51. doi: 10.1208/s12248-012-9337-6. Epub 2012 Mar 6.